The clinical decision support device mitigating drug therapy for all pts has poorly usable functionality such that it pressures the user and defaults to heparin therapy for protection from thrombosis, but fails to consider the frequent situations when the pt is already on an anticoagulant such as warfarin or noacs.It requires a significant amount of clinician time to click the way out of the morass of the flawed decision tree to cancel heparin.It is sufficiently onerous that it is much easier to simply allow the pt to remain over anticoagulated, as was the case in this pt.This puts most pts at higher risk of bleeding events.
|